Independent analysis examines Fridays' published TRT program structure, delivery format options, and what clinical research indicates for men evaluating prescription testosterone pathways heading into ...

Annalisa (Nalis) Merelli is a contributing writer at STAT focused on boys’ and men’s health. The first thing Abraham Morgentaler learned about testosterone is that it’s a brain hormone. It was in a ...

It is expected that Herjuema, Celltrion's anticancer drug, will be able to be administered as a subcutaneous (SC) injection in under five minutes. Celltrion said on Dec. 8 that it plans to submit ...

Testosterone therapy costs vary widely depending on the formulation you use, with injections generally the most affordable and pellets the most expensive. Even if insurance covers your testosterone ...

In the U.S., testosterone is a controlled substance, so you’ll need a prescription to acquire it. While you take it, your provider will order blood tests and monitor you closely to ensure treatment is ...

Annalisa (Nalis) Merelli is a contributing writer at STAT focused on boys’ and men’s health. Increased physical stamina. “Facility of intellectual labour.” A longer jet of urine. These were some of ...

You probably think of testosterone as the male sex hormone. Indeed, the FDA currently only approves supplemental testosterone treatment — available as injections, topical creams and gels, patches, ...

Compared with placebo, significantly greater proportions of patients treated with Tremfya achieved clinical remission and endoscopic improvement. HealthDay News — The US Food and Drug Administration ...

The FDA has approved Merck & Co.’s under-the-skin version of Keytruda, reducing treatment time burden for patients while granting the world’s bestselling drug potential blockbuster revenue protection.

Please provide your email address to receive an email when new articles are posted on . Leqembi Iqlik is the first approved in-home anti-amyloid injectable for early Alzheimer’s disease. Patients ...

The US Food and Drug Administration (FDA) has approved the biologics license application for a subcutaneous formulation of lecanemab (Leqembi Iqlik) for weekly maintenance dosing to treat Alzheimer’s ...

TORONTO -- An investigational subcutaneous autoinjector showed comparable efficacy and safety to the IV formulation of lecanemab (Leqembi) for maintenance treatment in early Alzheimer's disease, ...